WESFARMERS LIMITED (WES)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

WES

WES - WESFARMERS LIMITED

FNArena Sector : Consumer Products & Services
Year End: June
GICS Industry Group : Food & Staples Retailing
Debt/EBITDA: 1.97
Index: ASX20 | ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Wesfarmer is an Australian conglomerate with interests predominantly in Australian and New Zealand retail companies. It owns Bunnings, Kmart, Officeworks and Target, amongst others. Founded as the Westralian Farmers Co-operative in 1914 it became a listed entity in November 1984.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$80.90

17 Nov
2025

-0.230

OPEN

$80.39

-0.28%

HIGH

$81.31

1,174,485

LOW

$79.92

TARGET
$86.467 6.9% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ALD . PFP .
FNARENA'S MARKET CONSENSUS FORECASTS
WES: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 258.0 249.4 xxx
DPS (cps) xxx 356.0 251.0 xxx
EPS Growth xxx 14.3% - 3.3% xxx
DPS Growth xxx 79.8% - 29.5% xxx
PE Ratio xxx N/A 32.4 xxx
Dividend Yield xxx N/A 3.1% xxx
Div Pay Ratio(%) xxx 138.0% 100.6% xxx

Dividend yield today if purchased 3 years ago: 7.48%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.39

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 03/09 - ex-div 107c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx258.0
DPS All xxxxxxxxxxxxxxx356.0
Sales/Revenue xxxxxxxxxxxxxxx45,576.0 M
Book Value Per Share xxxxxxxxxxxxxxx809.6
Net Operating Cash Flow xxxxxxxxxxxxxxx4,568.0 M
Net Profit Margin xxxxxxxxxxxxxxx6.42 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx32.92 %
Return on Invested Capital xxxxxxxxxxxxxxx15.44 %
Return on Assets xxxxxxxxxxxxxxx9.78 %
Return on Equity xxxxxxxxxxxxxxx32.92 %
Return on Total Capital xxxxxxxxxxxxxxx19.03 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx1,130.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1,149 M
Long Term Debt xxxxxxxxxxxxxxx10,019 M
Total Debt xxxxxxxxxxxxxxx11,168 M
Goodwill - Gross xxxxxxxxxxxxxxx3,790 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx638 M
Price To Book Value xxxxxxxxxxxxxxx10.47

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx1,147.0 M
Capex % of Sales xxxxxxxxxxxxxxx2.52 %
Cost of Goods Sold xxxxxxxxxxxxxxx38,614 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx3,135 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1,209 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

-0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

4

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

30/10/2025

3

Neutral

$90.00

11.25%

In a quick response to Wesfarmers' AGM trading update, Citi suggests today's update indicates both Bunnings and Kmart are performing in line with the update provided in August.

Officeworks has seen sales momentum continue, though a reset of this business will see EBIT in 1H26 to be down -$15-$25m on the previous period last year.

No major changes are anticipated in consensus forecasts.

Neutral. Target $90.

FORECAST
Citi forecasts a full year FY26 dividend of 222.00 cents and EPS of 246.20 cents.
Citi forecasts a full year FY27 dividend of 237.00 cents and EPS of 262.30 cents.

Morgans

xx/xx/xxxx

4

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

05/11/2025

4

Underweight

$70.50

-12.86%

Wesfarmers’ AGM update was slightly softer, with sales broadly in line but cost pressures and Officeworks restructuring leading to modest downgrades in earnings estimates for Jarden.

Officeworks now expects around a -20% decline in segment earnings (EBIT), reflecting -$15 to –$25m in combined restructuring and trading headwinds. Bunnings’ sales are tracking ahead of last half, led by the consumer segment, while Kmart and Health divisions are performing in line with trends.

The analyst lowers its EPS forecasts by 1–2% for FY26–28, mainly due to Officeworks and weaker industrials trading, partly offset by strength in Health.

Jarden retains an Underweight rating, citing valuation concerns and limited near-term catalysts, with the next phase of growth likely to require more capital-intensive investment. Target price falls to $70.50 from $73.40.

FORECAST
Jarden forecasts a full year FY26 dividend of 374.00 cents and EPS of 253.70 cents.
Jarden forecasts a full year FY27 dividend of 248.00 cents and EPS of 282.90 cents.
Access Extra Coverage Research History >

WES STOCK CHART

FNArena News on WES

1
Rudi’s View: Amcor, Charter Hall, Challenger, Goodman, Woolworths & More

Nov 06 2025 - Rudi's View
2
Australian Broker Call *Extra* Edition – Nov 06, 2025

Nov 06 2025 - Daily Market Reports
3
October In Review: Growth Slips Value Rips

Nov 05 2025 - Australia
4
Australian Broker Call *Extra* Edition – Oct 30, 2025

Oct 30 2025 - Daily Market Reports
5
Rudi’s View: Identifying Quality Opportunities

Oct 29 2025 - Rudi's View

Latest Consumer Products & Services News

1
Rudi’s View: Antipa, Computershare, IPH, Lynas, Macquarie, Rio Tinto & More

Nov 13 2025 - Rudi's View
2
AI & Competitor Anxiety Dominate REA Sentiment

Nov 11 2025 - Australia
3
Market Not Valuing Pexa Group’s UK Potential

Nov 07 2025 - Small Caps
4
Diversification Drives Jumbo Growth Outlook

Oct 22 2025 - Small Caps
5
Treasure Chest: REA Group

Oct 21 2025 - Treasure Chest
6
Enthusiasm For Treasury Wine Runs Dry

Oct 15 2025 - Australia
7
Canadian Purchase Lifts Eagers Into Global Top 5

Oct 08 2025 - Australia
8
SiteMinder’s Deeper Connectivity For Growth

Oct 01 2025 - Small Caps
9
Premier Investments’ FY26 Turnaround Potential

Oct 01 2025 - Small Caps
10
Enlarged Myer Stumbles, But Remains Confident

Sep 25 2025 - Small Caps